Hepatitis C treatment completion in individuals with psychiatric comorbidity and depression

Gastroenterology Nursing

Volumn 34, Issue 2, 2011, Pages 102-106

  Gardenier, Donald ^a   Wisnivesky, Juan ^a   McGinn, Lata K ^b   Kronish, Ian M ^a   McGinn, Thomas G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN;

ADDICTION; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; EPIDEMIOLOGY; FEMALE; HEPATITIS C; HUMAN; MALE; MENTAL DISEASE; MIDDLE AGED; NURSING; PATIENT COMPLIANCE; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

ANTIVIRAL AGENTS; COHORT STUDIES; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; MENTAL DISORDERS; MIDDLE AGED; NEW YORK; PATIENT COMPLIANCE; RIBAVIRIN; SAMPLING STUDIES; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 79955106212     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/SGA.0b013e31820f9b8f     Document Type: Article

References (19)

1. Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144(10), 705-714. (Pubitemid 46780630)
2. Bacon, B. R. (2008). Workforce issues in hepatology: What is needed? Hepatology, 47(6), 1801-1804. (Pubitemid 351945543)
3. Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. (1996). Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. Journal of Personality Assessment, 67, 588-597. (Pubitemid 26382973)
4. Butt, A. A., Khan, U. A., McGinnis, K. A., Skanderson, M., & Kent Kwoh, C. (2007). Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans. Journal of Viral Hepatitis, 14, 890-896. (Pubitemid 350211412)
5. Edlin, B. R. (2005). Five million Americans infected with the hepatitis C virus: A corrected estimate. Hepatology, 42 (4, Suppl. 1), 213A.
6. Evon, D., Verma, A., Dougherty, K., Batey, B., Russo, M., Zacks, S., et al. (2007). High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities. Digestive Diseases & Science, 52, 3251-3258. (Pubitemid 47512531)
7. Farley, J. E., Dial, D. J., & Littleton-Kearney, M. (2006). Management of hematologic and neuropsychiatric side effects in treatment of chronic HCV infection. Journal for Nurse Practitioners, 2(1), 38-45. (Pubitemid 43362763)
8. Gardenier, D., Neushotz, L., & O'Connor, N. (2007). Medical/psychiatric comanagement by nurse practitioners in chronic hepatitis C treatment: a case study. Archives of Psychiatric Nursing, 21(2), 87-91.
9. Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009). Diagnosis, management and treatment of hepatitis C: An update. Hepatology, 49(4), 1335-1374.
10. McGinn, T. G., O'Connor-Moore, N., Alfandre, D., Gardenier, D., & Wisnivesky, J. (2008). Validation of a hepatitis C screening tool in primary care. Archives of Internal Medicine, 168(18), 2009-2013.
11. Morrill, J. A., Shrestha, M., & Grant, R. W. (2005). Barriers to the treatment of hepatitis C. Patient, provider, and system factors. Journal of General Internal Medicine, 20(8), 754-758. (Pubitemid 41141009)
12. Paterson, B. L., Backmund, M., Hirsch, G., & Yim, C. (2007). The depiction of stigmatization in research about hepatitis C. International Journal of Drug Policy, 18, 364-373. (Pubitemid 47376916)
13. Rowan, P. J., Dunn, N. J., El-Serag, H. B., & Kunik, M. E. (2007). Views of hepatitis C virus patients delayed from treatment for psychiatric reasons. Journal of Viral Hepatitis, 14, 883-889. (Pubitemid 350211411)
14. Schaefer, M., Hinzpeter, A., Mohmand, A., Janssen, G., Pich, M., Schwaiger, M., et al. (2007). Hepatitis C treatment in "difficultto- treat" psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects. Hepatology, 46(4), 991-998. (Pubitemid 350144763)
15. Shehab, T. M., Sonnad, S. S., & Lok, A. S. (2001). Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. Journal of Viral Hepatology, 8(5), 377-383. (Pubitemid 34205892)
16. Sylvestre, D., & Clements, B. (2007). Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. European Journal of Gastroenterology and Hepatology, 19, 741-747. (Pubitemid 47266701)
17. Sylvestre, D., Litwin, A., Clements, B., & Gourevitch, M. (2005). The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone. Journal of Substance Abuse Treatment, 29, 159-165. (Pubitemid 41383828)
18. U. S. Department of Health and Human Services. (2002). Consensus conference statement on the management of hepatitis C. Bethesda, MD: Author.
19. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361-370. (Pubitemid 13098606)